13Mar2018 Avillion Signs Co-Development Agreement with Pearl Therapeutics Inc. (part of AstraZeneca) to Conduct Clinical Development of PT027 in Asthma
30Mar2017 Avillion signs Clinical Co-Development Agreement with Merck to Advance Anti IL-17 A/F Nanobody® in Psoriasis